Full-time, fixed-term position through to 31 December 2027
Base salary will range from $83,698 – $111,431 (Academic Level A) + 17% Superannuation
Based at the Translational Research Institute at our Dutton Park campus
This is an exciting opportunity for a visionary and inquisitive Postdoctoral Research Fellow to advance cutting-edge research in cellular and antibody-based immunotherapies within a highly collaborative and translational research environment. Working alongside leading researchers in CAR-NK and CAR-T cell engineering and antibody immunotherapy, you will contribute to ambitious cancer research programs with real-world impact, while building your independent research profile in a supportive, purpose-driven team aligned with UQ’s commitment to creating change together.
Key responsibilities will include:
Research: Produce high-quality research outputs through publication in reputable outlets; contribute to competitive research funding applications; collaborate on interdisciplinary projects; and support translation and commercialisation of research outcomes.
Supervision and Researcher Development: Contribute to supervision of Honours, Masters and/or HDR students; support researcher development through feedback and mentoring; and, where appropriate, assist with managing research support staff.
Citizenship and Service: Contribute to internal service roles and committees; and begin developing external partnerships with industry, government and the wider community.
This is a research focused position. Further information can be found by viewing UQ’s Criteria for Academic Performance
Completion or near completion of a PhD in immunology, cell biology, molecular biology, or a related discipline.
An emerging research profile in cellular and/or antibody-based immunotherapy.
Hands-on expertise in cell engineering techniques, including CAR-T and/or CAR-NK generation and functional characterisation.
Proficiency in molecular biology methodologies, including plasmid design, viral preparation, and transduction protocols.
Experience with in vitro and in vivo immunological assays, including cell culture, tumour killing assays, cytokine profiling, and mouse models of cancer.
Proficiency in flow cytometry, including panel design, acquisition and data analysis.
Evidence of publications in refereed journals and presentations at conferences.
Experience contributing to applications for external research funding.
A collaborative, inclusive approach and the ability to work effectively within multidisciplinary research teams.
As part of the UQ community, you will work alongside some of the world’s brightest minds in an ambitious, inclusive environment where interdisciplinary collaboration is actively encouraged. UQ provides access to world-class research infrastructure, grant writing support and extensive professional development, empowering researchers to translate discovery into impact.
The benefits of joining UQ are broad and meaningful, including being part of a Group of Eight university, recognition of prior service with other Australian universities, up to 26 weeks of paid parental leave, 17.5% annual leave loading, flexible working arrangements, access to exclusive internal-only opportunities, and genuine career progression through the academic promotions process.
For more information about this opportunity, please contact A/Prof Fernando Guimaraes at f.guimaraes@uq.edu.au
For application inquiries, please reach out to the Talent Acquisition team at talent@uq.edu.au, stating the job reference number ( R-64606) in the subject line.
When you apply, please ensure you upload a resume, cover letter, and responses to the ‘About You’ section Please note that applications received via email will not be accepted.
Pre-employment checks may include verification of the right to work in Australia, qualifications, and other integrity and conduct requirements.
You must maintain unrestricted work rights in Australia for the duration of this appointment to apply. Employer sponsored work rights are not available for this appointment.
We are dedicated to equity, diversity and inclusion and encourage applications from candidates who may not meet every criterion but can demonstrate their potential relative to opportunity. We are happy to support accessibility needs throughout the recruitment process.
Applications close 25th of June 2026 at 11.00pm AEST (Job Reference Number: R-64606).
